Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
Hiroyuki Daikuhara, Kensaku Fukunaga, Tomie Ohshima Department of Internal Medicine, Sakaide City Hospital, Kagawa, Japan Purpose: This open-label controlled study compared the therapeutic efficacy of three representative angiotensin II receptor blockers (ARBs) in hypertensive patients with type 2 d...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Livro |
| Publicado em: |
Dove Medical Press,
2014-02-01T00:00:00Z.
|
| Assuntos: | |
| Acesso em linha: | Connect to this object online. |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|